Traveler Diarrhea
📧 Sign up to get email alerts when something new happens for Traveler Diarrhea.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model. [Phase 2]
Phase 2 trial evaluating once-daily IMM-124E (Travelan) for efficacy in a controlled human infection model in travelers with diarrhea condit…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model [Phase 2]
This update reports the completion of a Phase 2 trial evaluating IMM-124E (Travelan) for prevention of traveler’s diarrhea and related infec…
-
FDA approval · 2025-09-19FDA Approved: LOPERAMIDE HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved an oral generic version of loperamide hydrochloride from Bionpharma Inc under an Original ANDA.
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia
A clinical trial to determine the etiology of traveler's diarrhea among Australian tourists traveling to Southeast Asia; recruitment is ongo…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: A Phase 2 Bridging Study to Assess the New Formulation of ETVAX [Phase 2]
A Phase 2 bridging study evaluating a new formulation of the ETVAX vaccine has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct [Phase 4]
A Phase 4 clinical trial evaluating single-dose rifaximin versus azithromycin with loperamide adjunct for acute watery diarrhea, including t…
-
FDA approval · 2025-02-21FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for sulfamethoxazole and trimethoprim, granting approval of a generic p…
-
FDA approval · 2024-06-24FDA Approved: SULFAMETHOXAZOLE AND TRIMETHOPRIM — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for sulfamethoxazole and trimethoprim by Prasco Laboratories. This action confirms the approval of t…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Prevention of Traveler's Diarrhea [Phase 2]
A Phase 2 clinical trial evaluating prevention of traveler's diarrhea has completed.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea in children aged 6 to 11.
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years [Phase 2]
Phase 2 study evaluating safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea in adolescents aged 12-17 is in progress with unkno…
-
FDA approval · 2021-12-13FDA Approved: ANTI DIARRHEAL — Supplemental Application (H E B)
FDA approved a supplemental application for a generic anti-diarrheal drug containing loperamide hydrochloride (LOPERAMIDE HCL).
-
FDA approval · 2021-08-11FDA Approved: LOPERAMIDE HYDROCHLORIDE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original application for loperamide hydrochloride from Dr. Reddy's Laboratories Inc., enabling a generic product to treat d…
-
FDA approval · 2020-07-28FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) filed by Sun Pharmaceutical Industries, Inc. to upda…
-
CLINICAL_TRIALS trial_result · 2019-12-05Clinical Trial Update: Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea [Phase 3]
A Phase 3 trial comparing rifaximin with Xifaxan 200 mg for traveler’s diarrhea has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S. [Phase 3]
Phase 3 clinical trial update on prevention of travelers' diarrhea in subjects traveling outside the U.S. completed.
-
CLINICAL_TRIALS trial_result · 2019-07-08Clinical Trial Update: Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea [Phase 1]
Phase 1 safety study of a chimeric vaccine to prevent ETEC diarrhea has completed with results posted.
-
FDA approval · 2019-05-28FDA Approved: LOPERAMIDE HYDROCHLORIDE — Supplemental Application (Aurohealth LLC)
FDA approved a supplemental application for loperamide hydrochloride from Aurohealth LLC under ANDA206548, confirming the regulatory status …
-
CLINICAL_TRIALS trial_result · 2019-02-27Clinical Trial Update: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea [Phase 3]
Phase 3 trial comparing Rifamycin SV-MMX tablets to ciprofloxacin for acute traveler’s diarrhea has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli [NA]
Completed clinical trial evaluating PTM202 for modulation of host resistance to diarrheagenic Escherichia coli in travelers with traveler's …
-
CLINICAL_TRIALS trial_result · 2018-04-10Clinical Trial Update: Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD) [Phase 3]
Phase 3 study evaluating the safety and efficacy of Rifamycin SV MMX for traveler’s diarrhea has completed and results were posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea [Phase 3]
Phase 3 trial CBS-2004 for prevention of traveler's diarrhea was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Dose-Finding Study of WS6788A and LSN03-016011/A Enterotoxigenic E. Coli ETEC Challenge Strains That Express CS17 [Phase 1]
A Phase 1 dose-finding trial evaluated WS6788A and LSN03-016011/A against CS17-expressing enterotoxigenic E. coli strains in a challenge-mod…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea [NA]
An ambulatory-treatment trial for travelers' diarrhea conducted by Uniformed Services University of the Health Sciences has been terminated.
-
FDA approval · 2015-12-15FDA Approved: LOPERAMIDE HYDROCHLORIDE — Original Application (Aurohealth LLC)
FDA approved the original application for loperamide hydrochloride from Aurohealth LLC, enabling generic access to the anti-diarrheal medica…